NasdaqCM - Nasdaq Real Time Price • USD
Cytosorbents Corporation (CTSO)
As of 1:51 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.12 | -0.1 | -0.36 | -0.2 |
Low Estimate | -0.15 | -0.12 | -0.43 | -0.26 |
High Estimate | -0.1 | -0.07 | -0.31 | -0.16 |
Year Ago EPS | -0.17 | -0.14 | -0.64 | -0.36 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 9.78M | 9.85M | 40.3M | 47.76M |
Low Estimate | 9M | 9.4M | 39.51M | 44.11M |
High Estimate | 10.2M | 10.34M | 41.33M | 49.76M |
Year Ago Sales | 9.45M | 9.42M | 36.35M | 40.3M |
Sales Growth (year/est) | 3.50% | 4.60% | 10.90% | 18.50% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.13 | -0.11 | -0.14 | -0.14 |
EPS Actual | -0.17 | -0.14 | -0.21 | -0.13 |
Difference | -0.04 | -0.03 | -0.07 | 0.01 |
Surprise % | -30.80% | -27.30% | -50.00% | 7.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.12 | -0.1 | -0.36 | -0.2 |
7 Days Ago | -0.12 | -0.1 | -0.36 | -0.2 |
30 Days Ago | -0.12 | -0.09 | -0.37 | -0.21 |
60 Days Ago | -0.13 | -0.11 | -0.46 | -0.21 |
90 Days Ago | -0.13 | -0.11 | -0.46 | -0.21 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CTSO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 29.40% | -- | -- | 1.50% |
Next Qtr. | 28.60% | -- | -- | 12.10% |
Current Year | 43.80% | -- | -- | 4.40% |
Next Year | 44.40% | -- | -- | 13.20% |
Next 5 Years (per annum) | -- | -- | -- | 10.97% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/15/2024 |
Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/29/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/2/2023 |
Reiterates | HC Wainwright & Co.: Buy | 5/3/2023 |
Reiterates | HC Wainwright & Co.: Buy | 3/10/2023 |
Maintains | HC Wainwright & Co.: Buy | 11/4/2022 |
Related Tickers
AEMD Aethlon Medical, Inc.
1.4330
-6.03%
RCEL AVITA Medical, Inc.
8.53
+2.71%
CLPT ClearPoint Neuro, Inc.
5.16
-2.82%
DCTH Delcath Systems, Inc.
5.40
+2.66%
AXGN AxoGen, Inc.
6.67
+2.30%
NMTC NeuroOne Medical Technologies Corporation
1.1392
+0.81%
IDYLF Imaging Dynamics Company Ltd.
0.0300
0.00%
VYCO Vycor Medical, Inc.
0.0840
0.00%
ENCW Enchanted World Inc.
0.0003
0.00%
ESMC Escalon Medical Corp.
0.2000
-16.67%